Articles

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Department of Hematology, Amsterdam UMC, location VU University Medical Center, the Netherlands;
Department of Hematology, Amsterdam UMC, location VU University Medical Center, the Netherlands;
Department of Hematology, UMC Groningen, University of Groningen, Groningen, the Netherlands;
Dept. of Hematology, HOVON Data Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;
Dept. of Hematology, UMC Utrecht Cancer Centre, University Medical Centre Utrecht, the Netherlands;
Department of Hematology Erasmus MC Cancer Institute, Rotterdam, the Netherlands;
Department of Hematology, University Hospitals Leuven, Leuven, Belgium;
Department of Hematology, UMC Groningen, University of Groningen, Groningen, the Netherlands;
Department of Hematology, Leiden University Medical Centre, Leiden, the Netherlands;
Department of Hematology, Leiden University Medical Centre, Leiden, the Netherlands;
Department of Hematology, Oncology Centre Isala, Zwolle, the Netherlands;
Department of Hematology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands;
Department of Internal Medicine, Admiraal de Ruijter Hospital Goes, the Netherlands;
Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, the Netherlands;
Department of Internal Medicine, Tweesteden Hospital, Tilburg, the Netherlands;
Department of Internal Medicine, Tjongerschans Hospital, Heerenveen, the Netherlands;
Department of Internal Medicine, Haga Hospital, the Netherlands;
Department of Internal Medicine, Maxima Medisch Centrum, Veldhoven, the Netherlands;
Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands;
Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands;
Department of Hematology, Maastricht UMC, Maastricht, the Netherlands;
Department of Internal Medicine, St Antonius Hospital, Nieuwegein, the Netherlands;
Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands;
Department of Pathology, Amsterdam UMC, location VU University Amsterdam, the Netherlands;
Dept. of Pathology and Medical Biology, UMC Groningen, University of Groningen, the Netherlands;
Dept. of Pathology and Medical Biology, UMC Groningen, University of Groningen, the Netherlands;
Dept. Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands;
Department of Radiology and Nuclear Medicine, Gelre Hospital, Apeldoorn, the Netherlands;
Dept. of Radiology and Nuclear Medicine, Amsterdam UMC, VU University Amsterdam, the Netherlands;
Department of Hematology, Amsterdam UMC, location VU University Medical Center, the Netherlands;
Department of Pathology, Amsterdam UMC, location VU University Amsterdam, Amsterdam, the Netherlands;
Dept of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands
Haematologica Early view Dec 19, 2019 https://doi.org/10.3324/haematol.2019.238162